United Therapeutics | UTHR - Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Amarin USD 449.41M 9.87M 2026-03
Ardelyx USD 148.62M 18.33M 2026-03
Baxter International USD 6.04B 86M 2026-03
Bayer EUR 28.85B 2.9B 2026-03
BioCryst Pharmaceuticals USD -553.84M 434.69M 2026-03
Biogen USD 18.65B 394.9M 2026-03
BioMarin Pharmaceutical USD 6.21B 125.11M 2026-03
Emergent BioSolutions USD 649.3M 47.9M 2023-12
Esperion Therapeutics USD -307.93M 5.97M 2026-03
Gilead Sciences USD 23.52B 897M 2026-03
GlaxoSmithKline GBP 17.42B 1.05B 2026-03
Halozyme Therapeutics USD 219.64M 170.82M 2026-03
Insmed USD 704.85M 34.12M 2026-03
Ionis Pharmaceuticals USD 491.41M 2.32M 2026-03
J&J USD 81.19B 358M 2026-03
Lexicon Pharmaceuticals USD 202.86M 95.32M 2026-03
Moderna USD 7.41B 1.24B 2026-03
Omeros USD -228.68M 15.13M 2025-06
Pfizer USD 90.1B 3.63B 2026-03
PTC Therapeutics USD -180.46M 24.85M 2026-03
Regeneron Pharmaceuticals USD 31.42B 166.7M 2026-03
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sarepta Therapeutics USD 1.51B 364.48M 2026-03
Teva Pharmaceutical Industries USD 8.23B 314M 2026-03
United Therapeutics USD 5.9B 1.2B 2026-03
Vertex Pharmaceuticals USD 19.36B 696.1M 2026-03